Which Types of Bioinformatics Inventions Are Eligible for Patent Protection?
Requires Subscription or Fee PDF


patent law
computational biology
intellectual property


The field of bioinformatics is flourishing, and strong growth is only projected to continue. Like any cutting edge technology, bioinformatics requires an integrated IP strategy involving patent, trade secret, and copyright laws. The patent system in particular can be a powerful protection for commercializing bioinformatics inventions as long as a corresponding patent application meets certain patent law standards. Recently, the most rapidly evolving of these patent law standards—patent eligibility—came to a crescendo last year when the Supreme Court in Alice v. CLS Bank introduced a two-step test for determining whether computer-implemented inventions are patent-eligible. Since then, other courts and the USPTO have applied the test on inventions implemented on a computer and/or using the Internet with fact-dependent results. Here, we discuss how these decisions relate to bioinformatics inventions. We then analyze bioinformatics patents that have recently issued post-Alice. While the law remains relatively underdeveloped, it becomes clear that relying on a general purpose computer to perform routine or conventional steps in a claim will not infuse patent-eligibility into a claim. However, bioinformatics inventions remain patentable, especially when the patent prosecution team properly and persuasively presents the technical improvements and commercial embodiments.

Requires Subscription or Fee PDF



Michael A. Gollin, Protecting Bioinformatics’ Value, AMERICAN CHEMICAL SOCIETY, October 2004, at 19, available at http://pubs.acs.org/subscribe/archive/mdd/v07/i10/pdf/1004business3.pdf.

U.S.C. § 101.


Alice v. CLS Bank, 134 S. Ct. 2347 (U.S. 2014).

I/P Engine, Inc. v. AOL Inc. 576 Fed App’x 982, 995 (Fed. Cir. 2014).

Digitech Image Techs. v. Elecs. for Imaging, Inc., 758 F.3d 1344, 1350 (Fed. Cir. 2014).

Planet Bingo, LLC v. VKGS LLC, 576 Fed App’x 1005, 1007 (Fed. Cir. 2014).

Buysafe, Inc. v. Google, Inc., 765 F.3d 1350, 1355 (Fed. Cir. 2014).

Ultramercial, Inc. v. Hulu, LLC, 772 F.3d 709, 715 (Fed. Cir. 2014).

Content Extraction and Transmission LLC v. Wells Fargo Bank, National Association, 2013-1588, -1589, -2014-1112, -1687, at 7 (Fed. Cir. 2014).

DDR Holdings, LLC v. Hotels.com, L.P., 773 F.3d 1245 (Fed. Cir. 2014).

Gottschalk v. Benson, 409 U.S. 63, 64, 67 (1972).

Parker v. Flook, 437 U.S. 584, 593, 594 (1978).

U.S. Patent No. 8,935,102.

Notice of Allowance of U.S. Patent No. 8,935,102, page 5, mailed September 5, 2014.

U.S. Patent No. 8,924,159.

Interview Summary of U.S. Patent No. 8,924,159, September 30, 2014.

Notice of Allowance of U.S. Patent No. 8,924,159, pages 2 and 3, mailed October 24, 2014.


U.S. Patent No. 8,935,099.

Notice of Allowance of US Patent No. 8,935,099, pages 2 and 3 (November 17, 2014).

Unless specified by prior arrangement, the author agrees to the following terms and assurances:

  1. For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
  2. I/we further give to the following assurances
    1. I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
    2. I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
    3. To the best of my/our knowledge, all the facts in the contribution are true and accurate;
    4. The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
    5. Nothing in the contribution is obscene or libellous;
    6. Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
    7. I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).
* Works by US government employees prepared as part of official duties are in the public domain and the authors are therefore exempt from copyright assignment.